321 – 330 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues
(
- Contribution to journal › Article
- 2002
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
(
- Contribution to journal › Article
-
Mark
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step
(
- Contribution to journal › Article
-
Mark
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer
(
- Contribution to journal › Article
-
Mark
Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease
(
- Contribution to journal › Article
-
Mark
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases I in plasma by immunoassay
(
- Contribution to journal › Article
-
Mark
Prediction of tumor heterogeneity in localized prostate cancer
(
- Contribution to journal › Article
-
Mark
Exogenous protein kinases A and C, but not endogenous prostasome-associated protein kinase, phosphorylate semenogelins I and II from human semen
(
- Contribution to journal › Article
-
Mark
A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein.
(
- Contribution to journal › Article
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
(
- Contribution to journal › Article